Frontage Holdings (HKSE:01521) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings 3-Year Dividend Growth Rate?

Frontage Holdings's Dividends per Share for the six months ended in Dec. 2023 was HK$0.00.

The historical rank and industry rank for Frontage Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

HKSE:01521's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 14.15
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Frontage Holdings's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Frontage Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Frontage Holdings's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Frontage Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frontage Holdings's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's 3-Year Dividend Growth Rate falls into.

Frontage Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Frontage Holdings (HKSE:01521) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Frontage Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	0.052
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frontage Holdings 3-Year Dividend Growth Rate Related Terms>

Frontage Holdings (HKSE:01521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

FGHQF:USA

Address

700 Pennsylvania Drive, Exton, PA, USA, 19341

Website

https://www.frontagelab.com

Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.

Frontage Holdings (HKSE:01521) Headlines

No Headlines